Shire Said in Advanced Talks to Acquire Drugmaker Baxalta

According to Bloomberg.com, “Shire Plc is in advanced talks to acquire Baxalta Inc. for about $32 billion in cash and stock, excluding debt, according to people familiar with the matter.  The two drugmakers may announce a deal as soon as this week, the people...

ICYMI: UK Paying Less for Cancer Drugs Than Other EU Countries

According to Pharmatimes.com, “The UK is paying less for new cancer drugs than most other countries in Europe, a new report has found.  The study in The Lancet Oncology also reveals that the prices of such drugs vary widely – from 28 percent to 388 percent –...